Table 3.
Effect of C. asiatica on physical fitness measured by hand grip.
| Hand strength | Pre-dose baseline score | Post-dose score | ||||
|---|---|---|---|---|---|---|
| 1 month | 2 month | 3 month | Delay | |||
| Left side (kg) | 23.65 ± 3.93 | 23.85 ± 4.33 | ||||
| Placebo | 23.05 ± 4.69 | 22.95 ± 4.57 | 23.48 ± 4.46 | F(0.0500, 3.57) = 0.6867, | F(0.0500, 1.19) = 3.5145, | |
| P = .563 | P = .0763 | |||||
| 23.03 ± 6.19 | 22.20 ± 3.11 | |||||
| CA250 | 21.55 ± 3.45 | 22.28 ± 2.96 | 22.70 ± 2.34 | F(0.0500, 3.57) = 1.5077, | F(0.0500, 1.19) = 2.8391, | |
| P = .2223 | P = .1084 | |||||
| 23.25 ± 4.98 | ||||||
| 23.93 ± 5.64 | F(0.0500, 1.19) = 1.6032, | |||||
| CA500 | 24.80 ± 7.88 | 23.90 ± 6.59 | 22.98 ± 5.30 | F(0.0500, 3.57) = 1.3040, | P = .2208 | |
| P = .2820 | 24.80 ± 6.17 | |||||
| 25.75 ± 6.45 | F(0.0500, 1.19) = 0.0293, | |||||
| CA750 | 24.85 ± 6.29 | 25.50 ± 6.55 | 26.15 ± 7.30 | F(0.0500, 3.57) = 2.2607, | P = .8660 | |
| P = .0911 | ||||||
|
| ||||||
| Right side (kg) | 24.15 ± 5.09 | 23.95 ± 5.31 | ||||
| Placebo | 23.43 ± 5.63 | 23.33 ± 5.24 | 24.05 ± 5.44 | F(0.0500, 3.57) = 1.3691, | F(0.0500, 1.19) = 2.1713, | |
| P = .2614 | P = .1570 | |||||
| 23.35 ± 2.50 | ||||||
| 23.30 ± 3.11 | F(0.0500, 1.19) = 0.0381, | |||||
| CA250 | 23.40 ± 2.67 | 24.05 ± 3.78 | 23.38 ± 3.01 | F(0.0500, 3.57) = 1.2931, | P = .8474 | |
| P = .2856 | 24.00 ± 5.99 | |||||
| 25.93 ± 6.09 | F(0.0500, 1.19) = 3.5531, | |||||
| CA500 | 26.58 ± 7.95 | 24.7 ± 6.32 | 24.38 ± 5.16 | F(0.0500, 3.57) = 2.0774, | P = .0748 | |
| P = .1133 | 25.25 ± 6.34 | |||||
| 25.45 ± 5.27 | F(0.0500, 1.19) = 2.8239, | |||||
| CA750 | 26.18 ± 5.53 | 26.40 ± 5.44 | 26.98 ± 5.41 | F(0.0500, 3.57) = 2.0055, | P = .1092 | |
| P = .0617 | ||||||
Subjects were measured physical fitness by hand grip. Data are presented as mean ± SD. P- and F-values were compared between pre-dose baseline score and post-dose 1, 2, 3 month and 1 month after cessation of treatment (n = 20/group).